[{"NetIncomeLoss_1_Q2_USD":4420000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-686000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":24824000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-2457000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2572000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-3000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":7000.0,"AssetsCurrent_0_Q2_USD":127963000.0,"LongTermDebtCurrent_0_Q2_USD":22813000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":35311000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":17704000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":530000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":849000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":3878000.0,"InterestPaidNet_2_Q2_USD":1719000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":538000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":-1223000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":-2841000.0,"UnrecognizedTaxBenefits_0_Q2_USD":2127000.0,"CommonStockSharesIssued_0_Q2_shares":169584000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":7660000.0,"Assets_0_Q2_USD":212619000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":7000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-3000.0,"ShareBasedCompensation_2_Q2_USD":3666000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":4014000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.75,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"DeferredIncomeTaxAssetsNet_0_Q2_USD":45249000.0,"InventoryValuationReserves_0_Q2_USD":777000.0,"PreferredStockValueOutstanding_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":10659000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":5725000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4047000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":2.83,"EarningsPerShareBasic_2_Q2_USD":0.05,"EarningsPerShareBasic_1_Q2_USD":0.03,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":174813000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":174851000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-135000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-89000.0,"AccountsReceivableNetCurrent_0_Q2_USD":54224000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":1733000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1143000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":1815000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":14409000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-13963000.0,"IncreaseDecreaseInInventories_2_Q2_USD":427000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":8210000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":4427000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-960000.0,"OtherAssetsNoncurrent_0_Q2_USD":2523000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":45126000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":4552000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":345431000.0,"Liabilities_0_Q2_USD":80591000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"SharesPaidForTaxWithholdingForShareBasedCompensation_2_Q2_shares":626000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":2.46,"RepaymentsOfLongTermDebt_2_Q2_USD":15000000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":29655000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"ResearchAndDevelopmentExpense_2_Q2_USD":6687000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-633000.0,"CommonStockValueOutstanding_0_Q2_USD":1696000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2061000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3666000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":8411000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":325000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":168436000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":169043000.0,"LiabilitiesCurrent_0_Q2_USD":71975000.0,"AccountsPayableCurrent_0_Q2_USD":15797000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2232000.0,"NonoperatingIncomeExpense_1_Q2_USD":-1224000.0,"InterestExpense_2_Q2_USD":2097000.0,"InterestExpense_1_Q2_USD":1135000.0,"IncreaseDecreaseInContractWithCustomerAsset_2_Q2_USD":-2415000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":2841000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4244000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3878000.0,"LongTermDebtNoncurrent_0_Q2_USD":3338000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":7280000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":0.05,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":0.03,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":6415000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":5770000.0,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-1733000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":45126000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":2534000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":21060000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":25590000.0,"NetIncomeLoss_2_Q2_USD":8213000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-2000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":5563000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":9946000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":353000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":44978000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":87061000.0,"OperatingIncomeLoss_2_Q2_USD":12178000.0,"OperatingIncomeLoss_1_Q2_USD":6787000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":10000000.0,"InventoryNet_0_Q2_USD":18644000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":2675000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.4,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":2.15,"LiabilitiesAndStockholdersEquity_0_Q2_USD":212619000.0,"PreferredStockSharesAuthorized_0_Q2_shares":3000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":195000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1035000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":4242000.0,"ProfitLoss_2_Q2_USD":8213000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":726000.0,"StockholdersEquity_0_Q2_USD":132028000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2457000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16092000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":11094000.0,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":0.05,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":0.03,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-214413000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-8011000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":12007000.0,"CommonStockSharesOutstanding_0_Q2_shares":169584000.0,"EarningsPerShareDiluted_2_Q2_USD":0.05,"EarningsPerShareDiluted_1_Q2_USD":0.03,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":11717000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-1265000.0,"Ticker":"ATRS","CIK":"1016169","name":"ANTARES PHARMA, INC.","OfficialName":"Antares Pharma Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"948492298.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]